全文获取类型
收费全文 | 40500篇 |
免费 | 2734篇 |
国内免费 | 146篇 |
专业分类
耳鼻咽喉 | 257篇 |
儿科学 | 1384篇 |
妇产科学 | 936篇 |
基础医学 | 4709篇 |
口腔科学 | 741篇 |
临床医学 | 4258篇 |
内科学 | 8515篇 |
皮肤病学 | 713篇 |
神经病学 | 3986篇 |
特种医学 | 1309篇 |
外科学 | 6187篇 |
综合类 | 657篇 |
一般理论 | 60篇 |
预防医学 | 3327篇 |
眼科学 | 1003篇 |
药学 | 2860篇 |
中国医学 | 43篇 |
肿瘤学 | 2435篇 |
出版年
2023年 | 143篇 |
2022年 | 266篇 |
2021年 | 612篇 |
2020年 | 380篇 |
2019年 | 648篇 |
2018年 | 768篇 |
2017年 | 603篇 |
2016年 | 619篇 |
2015年 | 794篇 |
2014年 | 1138篇 |
2013年 | 1721篇 |
2012年 | 2630篇 |
2011年 | 2852篇 |
2010年 | 1613篇 |
2009年 | 1475篇 |
2008年 | 2618篇 |
2007年 | 2846篇 |
2006年 | 2781篇 |
2005年 | 2875篇 |
2004年 | 2715篇 |
2003年 | 2500篇 |
2002年 | 2503篇 |
2001年 | 389篇 |
2000年 | 244篇 |
1999年 | 406篇 |
1998年 | 620篇 |
1997年 | 457篇 |
1996年 | 416篇 |
1995年 | 354篇 |
1994年 | 304篇 |
1993年 | 307篇 |
1992年 | 262篇 |
1991年 | 226篇 |
1990年 | 214篇 |
1989年 | 211篇 |
1988年 | 193篇 |
1987年 | 168篇 |
1986年 | 194篇 |
1985年 | 193篇 |
1984年 | 294篇 |
1983年 | 245篇 |
1982年 | 314篇 |
1981年 | 277篇 |
1980年 | 275篇 |
1979年 | 148篇 |
1978年 | 150篇 |
1977年 | 151篇 |
1976年 | 129篇 |
1975年 | 109篇 |
1974年 | 127篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Stanley J. Szefler Alan K. Kamada Donna Hughes A. Manon Brenner Erwin W. Gelfand 《The Journal of asthma》1992,29(2):91-97
Alternative treatments such as troleandomycin methotrexate, gold, and intravenous gamma globulin are sometimes considered for severe asthmatics to minimize the need for systemic corticosteroids and reduce adverse effects. These alternative therapies may also be associated with significant toxicity and expense. The ability to reduce corticosteroid use and the need for alternative treatment interventions in 125 pediatric patients at our institution were reviewed. Because corticosteroid requirements were reduced significantly, only 23 of 125 children evaluated were considered for treatment alternatives with only 10 receiving such therapy. This study emphasizes the importance of a thorough and comprehensive review of corticosteroid requirements and usage prior to initiating alternative approaches to treatment in moderate to severe asthmatics as well as in patients thought to be “steroid-dependent.” 相似文献
102.
103.
Lorien Abroms Cynthia M Jorgensen Brian G Southwell Alan C Geller Karen M Emmons 《Health education & behavior》2003,30(1):29-43
This study employs focus group methodology to explore gender differences in sunscreen use. Guided by the theory of reasoned action, males and females were found to differ on each of the following constructs: behavior, behavioral beliefs, and normative beliefs. Males and females differed in their sunscreen use, with females adopting a more preventive style of sunscreen use and males a more reactive style. Males and females differed in their salient beliefs that motivated their sunscreen use, many of which were related to traditional American gender roles. In addition, although males and females were aware of both positive and negative sources of normative beliefs regarding sunscreen use, females received more encouragement from their mothers and peers than males. Findings are discussed in terms of their implications for the design of future interventions. 相似文献
104.
Efficient RT-PCR on platelet mRNA after long-term storage 总被引:1,自引:0,他引:1
We have developed a procedure permitting RT-PCR from mRNA even after a long-term storage (1 year) of platelet samples in ethanol (EtOH-platelets) at −80°C. To validate our method, we have analysed the human platelet alloantigen system (HPA-1) which is coded by β3 mRNA. We have also demonstrated the efficiency of amplification of part of the coding region for (i) αIIb subunit mRNA, (ii) αv subunit mRNA, and (iii) the seven transmembrane domain thrombin receptor mRNA. 相似文献
105.
106.
Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells 总被引:5,自引:0,他引:5
Low density lipoprotein (LDL) has been found to represent a suitable carrier for cytotoxic drugs that may target them to cancer. This study investigated whether very low density lipoprotein (VLDL), LDL and high density lipoprotein (HDL) can be used to effectively incorporate four cytotoxic drugs, 5-fluorouracil (5-FU), 5-iododeoxyuridine (IUdR), doxorubicin (Dox) and vindesine; characterized the complexes; and examined the effect of incorporation on drug cytotoxicity against HeLa cervical and MCF-7 breast carcinoma cells. Significant drug loading was achieved into all three classes of lipoproteins, consistent with the sizes and hydrophobicity of the drugs. The relative loading efficiency was found to be vindesine>IUdR>Dox>5-FU for all three classes of lipoproteins. As shown by electron microscopy (EM), drug incorporation did not affect the size or morphology of the lipoproteins. Differential scanning calorimetry (DSC) showed that drug loading did not significantly change the thermal transition temperature of core lipids in the lipoproteins. The transition enthalpy was changed only for LDL–Dox and LDL–vindesine. The drugs remained stable in the lipoproteins as determined by high performance liquid chromatography (HPLC). EM, DSC and HPLC data suggest that drugs were incorporated into lipoproteins without disrupting their integrity and drugs remained in their stable forms inside lipoproteins. Compared with free drugs in cytotoxicity assays, the IC50 values of LDL– and HDL–drug complexes were significantly lower (2.4- to 8.6-fold for LDL complexes and 2.5- to 23-fold for HDL complexes). All free or lipoprotein-bound drug formulations were comparably more cytotoxic against MCF-7 than HeLa cells. Upregulating the lipoprotein receptors enhanced, and downregulating them inhibited, the cytotoxicity, indicating the mechanistic involvement of lipoprotein receptor pathways. Complexes of all four drugs with VLDL, in contrast to LDL and HDL, had the same cytotoxicity as the four corresponding free drugs. Our results suggest that further studies are required of the potential of HDL to be a cancer targeting drug carrier. 相似文献
107.
Steven R. Alexander Gerald S. Arbus Khalid M. H. Butt Susan Conley Richard N. Fine Ira Greifer Alan B. Gruskin William E. Harmon Paul T. McEnery Thomas E. Nevins Nadia Nogueira Oscar Salvatierra Jr Amir Tejani 《Pediatric nephrology (Berlin, Germany)》1990,4(5):542-553
This report of the North American Pediatric Transplant Cooperative Study summarizes data contributed by 57 participating centers on 754 children with 761 transplants from 1 January 1989 to 16 February 1989. Data collection was initiated in October 1987 and follow-up of all patients is ongoing. Transplant frequency increased with age; 24% of the patients were less than 5 years, with 7% being under 2 years. Common frequent diagnoses were: aplastic/dysplastic kidneys (18%), obstructive uropathy (16%), and focal segmental glomerulosclerosis (12%). Preemptive transplant, i.e., transplantation without prior maintenance dialysis, was performed in 21% of the patients. Dialytic modalities pretransplant were peritoneal dialysis in 42% and hemodialysis in 25%. Bilateral nephrectomy was reported in 29%. Live-donor sources accounted for 42% of the transplants. Among cadaveric donors, 41% of the donors were under 11 years old. During the first post-transplant month, maintenance therapy was used similarly for live-donor and cadaver source transplants, with prednisone, cyclosporine, and azathioprine used in 93%, 83%, and 81%, respectively. Triple therapy with prednisone, cyclosporine, and azathioprine was used in 78%, 75%, and 75% of functioning cadaver source transplants at 6 months, 12 months, and 18 months as opposed to 60%, 63%, and 54% for live-donor procedures, with single-drug therapy being uncommon. Rehospitalization during months 1–5 occurred in 62% of the patients, with treatment of rejection and infection being the main causes. Additionally, 9% were hospitalized for hypertension. During months 6–12 and 12–17, 30% and 28% of the patients with functioning grafts were rehospitalized. Times to first rejection differed significantly for cadaver and live-donor transplants. The median time to the first rejection was 36 days for cadaver transplants and 156 days for live-donor transplants. Overall, 57% of treated rejections were completely reversible although the complete reversal rate decreased to 37% for four or more rejections. One hundred and fifty-two graft failures had occurred at the time of writing, with a 1-year graft survival estimate of 0.88 for live-donor and 0.71 for cadaver source transplants. In addition to donor source, recipient age is a significant prognostic factor for graft survival. Among cadaver donors, decreasing donor age is associated with a decreasing probability of graft survival. Thirty-five deaths have occurred; 16 attributed to infection and 19 to other causes. The current 1-year survival estimate is 0.94. There have been 9 malignancies.A list of all participating centers and the names of the investigators is printed on pages 552–553 相似文献
108.
Interleukin–2 and hyperthermia have been used individually to treat a variety of tumors in both experimental and human trials. Combined adoptive immunotherapy and hyperthermia is an exciting new line of investigation. Previous work in our laboratory has shown that combined local hyperthermia and rIL-2 therapy can significantly decrease the rate of tumor growth. In this study, we investigated the effect of combined whole-body hyperthermia (WBHT) and rIL-2 on the growth of subcutaneous MCA-105 murine tumors in C57BL/6 mice. Treatment of both microscopic (day 3) and macroscopic (day 10) tumors was evaluated. In the treatment of microscopic tumors, animals received either no treatment; rIL-2 (3 × 105 IU ip tid) on days 3–7; plus WBHT(41°C for 30 min) on days 3, 5, and 7; or WBHT only on days 3, 5, and 7. In treating macroscopic tumors, animals received either no treatment; rIL-2 on days 10–14; plus WBHT on days 10, 12, and 14; or WBHT only on days 10, 12, and 14. While combined treatment and WBHT alone had no significant effect on the growth of microscopic tumors, combined IL-2 and WBHT significantly reduced the rate of tumor growth of macroscopic tumors. These results suggest that the tumor microenvironment plays a critical role in combined WBHT and rIL-2 therapy, and may be due to effects of WBHT on the tumor vasculature. © 1993 Wiley-Liss, Inc. 相似文献
109.
110.
Should cervical ultrasonography be a routine staging investigation for lung cancer patients with impalpable cervical lymph nodes? 总被引:3,自引:0,他引:3
Alan D L Sihoe Tak Wai Lee Anil T Ahuja Anthony P C Yim 《European journal of cardio-thoracic surgery》2004,25(4):486-491
OBJECTIVES: Detection of cervical N3 lymph nodes is currently not a routine preoperative investigation for lung cancer patients. We designed a study to assess if the frequency and accuracy of detection of metastatic cervical lymph nodes using cervical ultrasonography (US) and fine needle aspiration (FNA) justify their routine use in all lung cancer patients with impalpable cervical lymph nodes. METHODS: Fifty patients with suspected and potentially operable non-small cell lung cancer were enrolled. Patients with palpable cervical lymph nodes were excluded. In addition to routine preoperative investigations, all patients received cervical US to determine the presence of cervical lymph nodes. Nodes suspicious of harboring malignancy according to a specific set of sonographic criteria (which include shape, echogenicity, nodal architecture, and vascular patterns) were subjected to biopsy by ultrasound-guided FNA. RESULTS: Normal cervical lymph nodes were detected by cervical US in 30 patients (60%). Cervical lymph nodes suspicious of harboring malignancy were detected in 10 patients (20%). FNA confirmed cervical nodal metastasis in four of these patients (8%). The TNM staging of two patients (4%) was revised up to stage IIIb as a result, excluding them from further surgery. Cost analysis suggests this technique to be cost-effective when used as a routine preoperative investigation to exclude patients from unnecessary surgical intervention. No mortality or complications were encountered in all patients. CONCLUSIONS: Cervical US and FNA is a safe and cost-effective method of evaluating the status of impalpable cervical lymph nodes in lung cancer patients. Further study is warranted to establish the role of cervical US and FNA in lung cancer staging algorithms. 相似文献